Javier Pinilla-Ibarz, MD, PhD, senior member of the Department of Malignant Hematology at Moffitt Cancer Center, discusses the biggest challenge in treating patients with chronic lymphocytic leukemia.
Javier Pinilla-Ibarz, MD, PhD, senior member of the Department of Malignant Hematology at Moffitt Cancer Center, discusses the biggest challenge in treating patients with chronic lymphocytic leukemia (CLL).
According to Pinilla-Ibarz, the challenges with treating this disease lie in managing, using, and sequencing the various drugs available for these patients. There are a number of mutations found in CLL that can help guide therapy.